HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

782.509

-9.855-1.24%

Number of Gainers:7

Number of Losers:25

Number of Flat:2

PE:- -

High:796.309

Open:790.928

Low:758.529

Close:792.364

Volume:202.03M

Turnover:7.24B

Market Cap:479.24B

Float Cap:429.85B

Loading ...

Linxi County Market Supervision Bureau Conducts Special Inspection on Contact Lenses

Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) Subsidiary Obtains Medical Device Registration Certificates

BOCOM International: Maintains "Buy" Rating on AKESO (09926) with Target Price of HK$183

Beijing Strong Biotechnologies,Inc. (300406.SZ) Receives Two Medical Device Registration Certificates

Market Chatter: Concerns Over Trial Data Cloud US Approval Chances for Akeso, Summit Lung Cancer Drug

MT Newswires Live

Jin Ying Fund's Ouyang Juan: China's Pharmaceutical Industry Upgrade Continues to Deliver, Focus on Innovative Drugs and Supply Chain

Hong Kong Stocks Movement | REMEGEN (09995) Surges Nearly 14% as Telitacicept's Marketing Application for Sjögren's Syndrome Treatment Accepted by CDE

SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection

Subdued Growth No Barrier To Acotec Scientific Holdings Limited (HKG:6669) With Shares Advancing 35%

Simply Wall St.

KINTOR PHARMA-B (09939): KT-939 Human Long-term Safety Trial Completes Full Subject Enrollment

Kintor Pharmaceutical Ltd. Announces Completion of Enrollment for Long-Term Human Safety Trial of Novel Tyrosinase Inhibitor KT-939

AI Computing Power Faces Volatility as Capital Rotates, Chemical and Healthcare Sectors Take the Lead, ETF 159363 Sees Fresh Buying Interest with 100% Pure Innovative Drug Index Launch

ZYLOXTB (02190) Repurchases 27,000 Shares for HK$702,100 on September 8

Daan Gene Co.,Ltd. (002030.SZ) Obtains Medical Device Registration Certificate for Human Immunodeficiency Virus Type 1 (HIV-1) DNA Detection Kit

Zhaoke Ophthalmology Grants 8 Million Share Options

MT Newswires Live

AH Stock Statistics | September 8

Hong Kong Stocks Movement | CANBRIDGE-B (01228) Surges Over 19% Again, Cumulative Gains Exceed 20-fold This Year as Three Products Pass Initial Review for Commercial Insurance Innovative Drug Directory

China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others

3 Asian Growth Companies Insiders Are Betting On

Simply Wall St.

Golden Eagle Fund: Focus on Long-term Earnings Improvement Amid High-Low Rotation, Watch Tech, Innovative Pharmaceuticals, Non-ferrous Metals, and Non-banking Sectors After Pullbacks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":782.509,"timestamp":1757405290965,"preClose":792.36365,"halted":0,"volume":202026123,"delay":0,"changeRate":-0.012437,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-9.854675,"latestTime":"09-09 16:00:00","open":790.9279,"high":796.30927,"low":758.5287,"amount":7240654723,"amplitude":0.047681,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"pbRate":6.405731,"peRate":-54.447465,"turnoverRate":0.007428,"increases":6,"decrements":26,"flats":1,"marketCap":479237751296,"floatMarketCap":429846563872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":796.30927,"amplitude":0.047681,"preClose":792.36365,"low":758.5287,"pbRate":"6.405731","latestPrice":782.509,"volume":202026123,"delay":0,"open":790.9279,"prevYearClose":331.1933,"prevWeekClose":797.475,"prevMonthClose":775.114,"prevQuarterClose":555.617,"fiveDayClose":783.844,"twentyDayClose":746.636,"sixtyDayClose":580.99,"secType":"PLATE","market":"HK","turnoverRate":0.007428,"peRate":-54.447465,"marketCap":479237751296,"floatMarketCap":429846563872,"timestamp":1757405290965,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":25,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167848110","title":"Linxi County Market Supervision Bureau Conducts Special Inspection on Contact Lenses","url":"https://stock-news.laohu8.com/highlight/detail?id=1167848110","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167848110?lang=en_us&edition=fundamental","pubTime":"2025-09-09 17:32","pubTimestamp":1757410329,"startTime":"0","endTime":"0","summary":"Recently, the Market Supervision Bureau of Linxi County, Inner Mongolia, conducted a comprehensive special inspection on contact lenses across the county. Enforcement officers focused on contact lens...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","09996","09997","BK1222","BK1574","BK1100"],"gpt_icon":0},{"id":"1191216794","title":"Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) Subsidiary Obtains Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1191216794","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191216794?lang=en_us&edition=fundamental","pubTime":"2025-09-09 17:18","pubTimestamp":1757409497,"startTime":"0","endTime":"0","summary":"Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) announced that its wholly-owned subsidiary Healgen Scientific LLC (referred to as \"American Healgen\") and controlling subsidiary Hangzhou Laihe...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","09997","BK1222","BK1574","BK1100","09996","688298","BK1583","BK0239"],"gpt_icon":0},{"id":"1161133067","title":"BOCOM International: Maintains \"Buy\" Rating on AKESO (09926) with Target Price of HK$183","url":"https://stock-news.laohu8.com/highlight/detail?id=1161133067","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161133067?lang=en_us&edition=fundamental","pubTime":"2025-09-09 16:24","pubTimestamp":1757406272,"startTime":"0","endTime":"0","summary":"BOCOM International issued a research report maintaining a \"Buy\" rating on AKESO (09926) with a target price of HK$183. To date, no approved drugs have achieved statistically significant overall...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU2476274720.SGD","LU0348783233.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU0417516738.SGD","LU0348784397.USD","IE00BPRC5H50.USD","BK1161","LU0348825331.USD","09926","LU0540923850.HKD","LU2476274308.USD","LU0348766576.USD","LU0348735423.USD","LU2488822045.USD","IE00B543WZ88.USD","LU0634319403.HKD","LU1720050803.USD","LU0561508036.HKD","LU0348767384.USD","LU0348827113.USD","LU1794554557.SGD","BK1574","LU0417516571.SGD"],"gpt_icon":1},{"id":"1101967842","title":"Beijing Strong Biotechnologies,Inc. (300406.SZ) Receives Two Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1101967842","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101967842?lang=en_us&edition=fundamental","pubTime":"2025-09-09 16:02","pubTimestamp":1757404952,"startTime":"0","endTime":"0","summary":"Beijing Strong Biotechnologies,Inc. (300406.SZ) announced that the company has recently received Medical Device Registration Certificates issued by the Beijing Municipal Food and Drug Administration....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","09996","BK1222","159883","300406","BK0239","BK1583","BK0077","BK0028","BK0012","BK1100","09997","BK1574"],"gpt_icon":0},{"id":"2566664944","title":"Market Chatter: Concerns Over Trial Data Cloud US Approval Chances for Akeso, Summit Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2566664944","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566664944?lang=en_us&edition=fundamental","pubTime":"2025-09-09 15:34","pubTimestamp":1757403256,"startTime":"0","endTime":"0","summary":"The prospects of US approval for Akeso  and Summit Therapeutics' ivonescimab lung cancer drug appear to be dimming after analysts identified discrepancies in its latest findings, Bloomberg reported Monday.Akeso's shares in Hong Kong were down nearly 3% in Tuesday's trade.New data released showed North American and European patients lived longer on the drug, but the results failed to impress analysts, the report said.A Leerink analyst noted the data failed to validate positive signals from research in China, while analysts at Piper Sandler & Co said the reading on the Asian vs. non-Asian subgroups was \"worse\" than they expected, according to the report.The results were also \"uninterpretable\" due to the fragmented subgroup data on North America and Europe patients, Bloomberg Intelligence analysts Javier Manso Polo and Sam Fazeli reportedly said.The latest development marks a second setback for the companies, after earlier data showed the drug improved progression-free survival but did no","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SMMF","LU0348825331.USD","LU1720050803.USD","IE00B543WZ88.USD","LU0348783233.USD","BK1161","LU0348766576.USD","LU0348735423.USD","IE00B5MMRT66.SGD","LU0540923850.HKD","LU0348767384.USD","LU1794554557.SGD","LU2476274720.SGD","LU0634319403.HKD","LU0348827113.USD","LU0561508036.HKD","09926","BK4211","BK1574","LU0417516571.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0348784397.USD","LU2778985437.USD","LU0417516738.SGD","LU2476274308.USD"],"gpt_icon":1},{"id":"1141902117","title":"Jin Ying Fund's Ouyang Juan: China's Pharmaceutical Industry Upgrade Continues to Deliver, Focus on Innovative Drugs and Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1141902117","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141902117?lang=en_us&edition=fundamental","pubTime":"2025-09-09 10:20","pubTimestamp":1757384446,"startTime":"0","endTime":"0","summary":"Pharmaceutical listed companies have completed their mid-2025 interim performance disclosures. Overall, the pharmaceutical industry's total sector revenue declined 3.06% year-over-year in the first...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK0250","BK1161","BK0010","BK0082","BK0028","600056","BK0185","06978","BK0188","BK0175","BK1574"],"gpt_icon":0},{"id":"1113451433","title":"Hong Kong Stocks Movement | REMEGEN (09995) Surges Nearly 14% as Telitacicept's Marketing Application for Sjögren's Syndrome Treatment Accepted by CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1113451433","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113451433?lang=en_us&edition=fundamental","pubTime":"2025-09-09 09:54","pubTimestamp":1757382857,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) surged nearly 14% in early trading, with the stock's year-to-date cumulative gain reaching as high as 6 times. As of press time, the stock was up 13.9% to HK$110.2, with trading...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223082519.USD","LU1223083913.SGD","LU2148510915.USD","LU1969619763.USD","BK1161","CDE","LU1064130708.USD","LU2488822045.USD","LU1064131003.USD","688331","BK1574","BK4017","LU1223082196.USD","BK1583","LU2328871848.SGD","BK0239","09995"],"gpt_icon":0},{"id":"1131898226","title":"SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1131898226","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131898226?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:16","pubTimestamp":1757376982,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that its non-wholly owned subsidiary, Huisheng Biopharmaceutical Co., Ltd. (Huisheng Bio), has received tacit approval from the Center for Drug Evaluation (CDE) of the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","06978","BK1574","BK1515","BK1593","BK4590","BK1600","GLP","159992","BK4144","00460"],"gpt_icon":0},{"id":"2566542706","title":"Subdued Growth No Barrier To Acotec Scientific Holdings Limited (HKG:6669) With Shares Advancing 35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566542706","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566542706?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:25","pubTimestamp":1757370321,"startTime":"0","endTime":"0","summary":"Acotec Scientific Holdings Limited ( HKG:6669 ) shares have continued their recent momentum with a 35% gain in the last...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6669/acotec-scientific-holdings-shares/news/subdued-growth-no-barrier-to-acotec-scientific-holdings-limi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6669/acotec-scientific-holdings-shares/news/subdued-growth-no-barrier-to-acotec-scientific-holdings-limi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1100","06669","BK1574","BK1587"],"gpt_icon":0},{"id":"1156364553","title":"KINTOR PHARMA-B (09939): KT-939 Human Long-term Safety Trial Completes Full Subject Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=1156364553","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156364553?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:20","pubTimestamp":1757370026,"startTime":"0","endTime":"0","summary":"KINTOR PHARMA-B (09939) announced that its independently developed novel high-efficiency tyrosinase inhibitor KT-939, which inhibits melanin production, has recently completed enrollment of all 130...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU0541501648.USD","LU0541502299.USD","BK1515","KT","09939","BK1161","BK4115"],"gpt_icon":0},{"id":"2566630254","title":"Kintor Pharmaceutical Ltd. Announces Completion of Enrollment for Long-Term Human Safety Trial of Novel Tyrosinase Inhibitor KT-939","url":"https://stock-news.laohu8.com/highlight/detail?id=2566630254","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566630254?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:12","pubTimestamp":1757369567,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical Ltd. Announces Completion of Enrollment for Long-Term Human Safety Trial of Novel Tyrosinase Inhibitor KT-939. Kintor Pharmaceutical Ltd. has announced the completion of enrollment for a long-term human safety trial of their novel tyrosinase inhibitor, KT-939. The study involves 130 subjects and aims to evaluate the safety of topical application of 0.2% KT-939 over 48 consecutive weeks. This trial has received approval from the Ethics Committee of Shanghai Skin Disease Hospital and is led by Professor Tan Yimei. The primary focus is on any adverse skin reactions related to the use of KT-939, which is designed to inhibit melanin production and has demonstrated antioxidant and anti-inflammatory effects. Previous trials have shown favorable efficacy and safety profiles. The results of the current long-term safety trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT striv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL4TRbDf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"1132250550","title":"AI Computing Power Faces Volatility as Capital Rotates, Chemical and Healthcare Sectors Take the Lead, ETF 159363 Sees Fresh Buying Interest with 100% Pure Innovative Drug Index Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1132250550","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132250550?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:03","pubTimestamp":1757333001,"startTime":"0","endTime":"0","summary":"On September 8th, during the bull market consolidation period, market volatility intensified. The ChiNext index, which had staged a strong rebound on Friday (September 5th), suddenly experienced a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","06978","BK1161","159363","159891"],"gpt_icon":0},{"id":"1198916691","title":"ZYLOXTB (02190) Repurchases 27,000 Shares for HK$702,100 on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1198916691","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198916691?lang=en_us&edition=fundamental","pubTime":"2025-09-08 18:18","pubTimestamp":1757326695,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that it repurchased 27,000 shares on September 8, 2025, at a cost of HK$702,100.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1587","BK1583","BK1100"],"gpt_icon":0},{"id":"1187600269","title":"Daan Gene Co.,Ltd. (002030.SZ) Obtains Medical Device Registration Certificate for Human Immunodeficiency Virus Type 1 (HIV-1) DNA Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1187600269","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187600269?lang=en_us&edition=fundamental","pubTime":"2025-09-08 17:38","pubTimestamp":1757324298,"startTime":"0","endTime":"0","summary":"Daan Gene Co.,Ltd. (002030.SZ) announced that the company has recently obtained a medical device registration certificate issued by the National Medical Products Administration. The certificate...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","159883","BK1574","BK4139","09997","09996","BK0168","BK0042","BK0159","BK0028","002030","BK0046","BK0122","BK4121","BK1583","DNA","BK0188","BK4109","BK1222","BK1100"],"gpt_icon":0},{"id":"2565260502","title":"Zhaoke Ophthalmology Grants 8 Million Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2565260502","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565260502?lang=en_us&edition=fundamental","pubTime":"2025-09-08 17:27","pubTimestamp":1757323670,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  awarded 8 million share options to 97 grantees on Sept. 5 under its post-IPO share option scheme, a Monday Hong Kong bourse filing said.Of the total, nearly 6 million options were granted to 90 employees, and nearly 2.1 million options were granted to seven grantees who are either directors and/or the firm's CEO.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1587","BK1191","06622","BK1583"],"gpt_icon":0},{"id":"1148042170","title":"AH Stock Statistics | September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1148042170","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148042170?lang=en_us&edition=fundamental","pubTime":"2025-09-08 16:16","pubTimestamp":1757319405,"startTime":"0","endTime":"0","summary":"As of the close on September 8, NE ELECTRIC (00042), HOLLY FUTURES (03678), and FUDANZHANGJIANG (01349) ranked as the top three AH stocks by premium rate, with premiums of 785.25%, 238.95%, and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU0106252389.USD","BK1174","BK1130","BK1610","IE00B031J352.USD","LU0049853897.USD","LU1813983027.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0588545904.SGD","BK1105","LU0289961442.SGD","GWLLY","00038","HK0000306685.HKD","BYDDY","LU0327786744.USD","BK1183","LU0214875030.USD","00187","BK1140","BK1149","LU1868837722.USD","LU0320764599.SGD","LU0828237940.HKD","BK1551","00719","LU1211504680.USD","LU2357125470.USD","LU2097828474.EUR","02603","IE00BGHQDM52.EUR","IE00BYV24P56.USD","BK1564","LU0315179316.USD","LU0531970944.HKD","LU0516422366.SGD","LU0594300179.USD","BK1123","BK1539","BK1144","LU0531971595.HKD","LU0588546209.SGD","LU0823414551.USD","LU0880133367.SGD","BK1206","LU1023057109.AUD","LU0828237510.HKD","LU1048596156.SGD","BK1191","BK1506","BK1236","LU1152091168.USD","01108","LU1242518931.SGD","BK1119","LU0052750758.USD","LU0181495838.USD","BK1523","LU0370786039.SGD","LU1688375341.USD","00358","002594","LU2148510915.USD","399300","LU0345780521.USD","LU2476274720.SGD","SG9999015952.SGD","LU0431992006.USD","00811","HK0000320264.USD","LU1880383440.USD","LU0175139822.USD","HK0000252152.HKD","LU1282649141.HKD","LU0244354667.USD","BK1141","02465","01276","BK1125","LU0865486749.SGD","LU2506951792.HKD","LU1719994722.HKD","LU2360107325.USD","LU0650527681.SGD","LU0173614495.USD","LU0254981946.USD","LU0228367735.SGD","IE00B5MMRT66.SGD","BK1582","BK1522","LU0509642566.USD","LU0572944931.SGD","LU0819121731.USD","LU0417516738.SGD","02039","LU0289739343.SGD","SG9999006514.SGD","IE00BD6J9T35.USD","BK1137","BK1565","LU1831875114.USD","LU0359202008.SGD","LU0886674414.USD","LU0819123356.HKD","00300","IE0034224299.USD","00317","BK1154","LU2348774022.SGD","LU0501845795.SGD","SG9999001226.SGD","LU0061477393.USD","LU0449515922.USD","LU1008478684.HKD","LU0516423091.SGD","LU0823040885.USD","LU2153592121.USD","LU0348825331.USD","02196","SG9999015986.USD","BK1198","LU2097828805.USD","LU0096374516.USD","LU0211977185.USD","LU1366334651.USD","BK1223","LU0828238088.HKD","LU1251922891.USD","BK1562","BK1554","00042","01349","LU0588545730.USD","LU2543165471.USD","LU0348827113.USD","LU0823038988.USD","LU1115378108.SGD","HYDD.SI","LU0979878070.USD","03678","LU0326950275.SGD","BK1568","LU0231483743.USD","LU0405327494.USD","02727","601633","BK1237","82333","BK1543","BK1593","LU0823426308.USD","LU1046422090.SGD","LU1366334578.USD","LU1861219969.SGD","BK1574","LU1960683339.HKD","LU2097828631.EUR","LU0588545490.SGD","LU0307460666.USD","IE00BVYPNQ40.USD","03750","BK1558","LU1675838814.USD","LU0469268626.HKD","IE00BZ08YT58.USD","SG9999002828.SGD","LU0039217434.USD","LU0228659784.USD","BK1560","BK1515","LU0164872284.USD","BK1505","LU0593848301.USD","LU0348814723.USD","LU0821914370.USD","LU0359201885.HKD","06869","LU1861214812.USD","LU2097828557.USD","BK1592","LU0918141705.HKD","LU0345780281.USD","LU1655091616.SGD","IE00B3M56506.USD","BK1521","LU0455707207.USD","BK1148","LU0540923850.HKD","BK1567","LU1961090484.USD","LU0561508036.HKD","BK1110","01211","LU1224709979.USD","LU1868838027.USD","HK0000306701.USD","BK1546","LU0890818403.SGD","IE00BVYPNP33.GBP","LU1242518857.USD","LU2039709279.SGD","LU2294711713.HKD","LU0634319403.HKD","LU0868486357.SGD","LU1770034418.SGD","LU0791591158.USD","LU0502904849.HKD","LU0505663152.USD","LU2097828714.EUR","IE00BZ08YR35.GBP","LU1064131003.USD","BK1509","SG9999006597.SGD","LU0359201612.USD","LU0163747925.USD","LU0449509016.USD","BK1214","LU0456846285.SGD","LU1105468828.SGD","BK1181","SG9999015978.USD","LU0456827905.SGD","LU0823426480.USD","HK0000252160.HKD","IE00BMCWC346.EUR","LU0708995583.HKD","IE00B031HY20.USD","06127","LU0048580855.USD","LU1282649067.USD","SG9999014674.SGD","LU1794554557.SGD","LU0348788117.USD","LU0511384066.AUD","LU0640798160.USD","LU0823414478.USD","01812","LU0072913022.USD","BK1561","02333","LU0143863784.USD","LU0054450605.USD","06185","BK1231","LU1808992512.USD","LU0594300419.USD","LU2226246903.HKD","LU0417516902.SGD","LU0348735423.USD","03606","LU1504937902.USD","LU1720050803.USD","LU0140636845.USD","BK1544","BK1507","81211","LU1282649810.SGD","LU0384037296.USD","00895","IE00B0169L03.USD","HK0000320223.HKD","BK1540","IE0008369823.USD","LU1993786604.SGD","LU0287142896.SGD","IE00BF5LJ272.USD","LU0259732245.USD","LU1188198961.HKD","LU0084288322.USD","LU0289960550.SGD","LU2125910500.SGD","IE0008368742.USD","LU0229945570.USD","LU0117841782.USD","LU0589944569.HKD","LU0348816934.USD","LU0918141887.USD","BK1514","IE00B29SXG58.USD","LU0543330566.HKD","03143","LU1868837565.USD","LU2242644610.SGD","LU0516423174.USD","SG9999003461.SGD","HK0000500386.USD","BK1116","01057","BK1171","LU0314109678.HKD","LU2778985437.USD","LU0791590937.USD","LU0348805143.USD","LU0463099449.HKD","01033","LU1880383366.USD","06693","IE0031814852.USD","LU0797268264.HKD","159982","BK1552","00753","LU0067412154.USD","LU0856984785.SGD","LU1064130708.USD","LU2476274308.USD","02359","BK1205","00525","BK1513","LU0605514214.HKD","02899","LU0269904917.USD","LU2249611893.SGD","LU0488056044.USD","LU0315178854.USD","BK1161","LU0737861699.HKD","LU0043850808.USD","LU0871576103.HKD","BK1594","LU0143863198.USD","LU0648948544.HKD","03968","BK1202","LU0823039010.USD","SG9999004220.SGD","LU0405327148.USD","LU0516422952.EUR","LU1807302812.USD","SG9999002463.SGD","BK1147","LU1282648689.USD","LU0106959298.USD","LU0516422440.USD","01800","LU1303224171.USD","02218","LU0862451753.SGD","LU2045819591.USD","BK1576","00991","BK1583","BK1537","LU2399975544.HKD","LU1328277881.USD","SG9999015945.SGD","00916","LU0165289439.USD","BK1530","LU0164865239.USD","IE00B543WZ88.USD","LU1226287529.USD","LU2449936058.SGD"],"gpt_icon":1},{"id":"1146642416","title":"Hong Kong Stocks Movement | CANBRIDGE-B (01228) Surges Over 19% Again, Cumulative Gains Exceed 20-fold This Year as Three Products Pass Initial Review for Commercial Insurance Innovative Drug Directory","url":"https://stock-news.laohu8.com/highlight/detail?id=1146642416","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146642416?lang=en_us&edition=fundamental","pubTime":"2025-09-08 15:34","pubTimestamp":1757316860,"startTime":"0","endTime":"0","summary":"CANBRIDGE-B (01228) surged over 19% again, with cumulative gains exceeding 2000% year-to-date. As of press time, the stock was up 15.51% to HK$2.83, with turnover of HK$66.91 million. On the news...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01228","06978","BK1161","159992"],"gpt_icon":0},{"id":"1152030014","title":"China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1152030014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152030014?lang=en_us&edition=fundamental","pubTime":"2025-09-08 14:36","pubTimestamp":1757313378,"startTime":"0","endTime":"0","summary":"China Merchants International released a research report stating that the Chinese pharmaceutical industry is expected to continue its upward trajectory, benefiting from positive factors including...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1583","06978","159992","BK1191","IE00BZ08YT58.USD","BK1161","01177","BK1515","BK1521","01801","LU2328871848.SGD","BK1589","IE00BZ08YS42.EUR","SG9999014674.SGD","LU2097828714.EUR","02273","LU0502904849.HKD","LU2097828805.USD","02367","02268","LU2097828474.EUR","LU0455707207.USD","BK1141","BK1574","LU2097828557.USD","LU2488822045.USD","BK0188","LU1969619763.USD","BK0010","BK0175","LU2097828631.EUR","BK0185","IE00BZ08YR35.GBP","BK1593","600056","BK0250","BK0082","BK1207","BK0028","LU2242644610.SGD","BK1219","01530"],"gpt_icon":1},{"id":"2565507667","title":"3 Asian Growth Companies Insiders Are Betting On","url":"https://stock-news.laohu8.com/highlight/detail?id=2565507667","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565507667?lang=en_us&edition=fundamental","pubTime":"2025-09-08 12:05","pubTimestamp":1757304337,"startTime":"0","endTime":"0","summary":"As global markets navigate economic uncertainties, the Asian market remains a focal point for investors seeking growth opportunities amid fluctuating indices and evolving economic landscapes. In this environment, companies with substantial insider ownership often attract attention as potential indicators of confidence in their long-term prospects.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2021000-choice2-main-header/1585186828000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2021000-choice2-main-header/1585186828000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/materials/szse-300568/shenzhen-senior-technology-material-shares/news/3-asian-growth-companies-insiders-are-betting-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/materials/szse-300568/shenzhen-senior-technology-material-shares/news/3-asian-growth-companies-insiders-are-betting-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1191","01477"],"gpt_icon":0},{"id":"1106444247","title":"Golden Eagle Fund: Focus on Long-term Earnings Improvement Amid High-Low Rotation, Watch Tech, Innovative Pharmaceuticals, Non-ferrous Metals, and Non-banking Sectors After Pullbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1106444247","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106444247?lang=en_us&edition=fundamental","pubTime":"2025-09-08 11:50","pubTimestamp":1757303459,"startTime":"0","endTime":"0","summary":"Last week, A-shares experienced high-level volatility and consolidation, with the ChiNext index rebounding against the trend while the main board saw significant pullbacks due to selling pressure....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159876","06978","BK1161","159992"],"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":265,"code":"91000000","status":"200"}]}}